Bisphosphonate Treatment of Osteogenesis Imperfecta

Summary

The primary purpose of this trial is to evaluate whether the investigational medication is safe, effective and has the ability to increase spine bone density in osteogenesis imperfecta (OI) patients.

Timeline

Start

2003-06

Primary completion

2007-05

Completion

2007-05

Drugs

Indications